Attenuation of adenosine-induced myocardial perfusion heterogeneity by atenolol and other cardioselective β-adrenoceptor blockers: A crossover myocardial perfusion imaging study

Journal of Nuclear Medicine

Volumn 51, Issue 7, 2010, Pages 1036-1043

  Reyes, Eliana ^a   Stirrup, James ^a   Roughton, Michael ^a   D'souza, Savio ^a   Underwood, S Richard ^a   Anagnostopoulos, Constantinos ^a,b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

blocker; Adenosine; Coronary artery disease; Myocardial perfusion imaging

Indexed keywords

ADENOSINE; ATENOLOL; BISOPROLOL; METOPROLOL; TETROFOSMIN TC 99M; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIAGNOSTIC AGENT; ORGANOPHOSPHORUS COMPOUND; TECHNETIUM COMPLEX; TECHNETIUM TC 99M 1,2 BIS(BIS(2 ETHOXYETHYL)PHOSPHINO)ETHANE; TECHNETIUM TC 99M 1,2-BIS(BIS(2-ETHOXYETHYL)PHOSPHINO)ETHANE; VASODILATOR AGENT;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CROSSOVER PROCEDURE; DISEASE SEVERITY; ELECTROCARDIOGRAPHY; HEART MUSCLE PERFUSION; HEMODYNAMICS; HUMAN; IMAGE ANALYSIS; MALE; MYOCARDIAL PERFUSION IMAGING; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BLOOD PRESSURE; CORONARY ARTERY BLOOD FLOW; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; HEART; HEART MUSCLE ISCHEMIA; HEART RATE; MIDDLE AGED; SCINTISCANNING;

ADENOSINE; ADRENERGIC BETA-ANTAGONISTS; AGED; ATENOLOL; BLOOD PRESSURE; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY DISEASE; CORONARY STENOSIS; CROSS-OVER STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEART RATE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS;

EID: 77954985890     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.073411     Document Type: Article

References (22)

1. Muller-Suur R, Eriksson SV, Strandberg LE, Mesko L. Comparison of adenosine and exercise stress test for quantitative perfusion imaging in patients on β-blocker therapy. Cardiology. 2001;95:112-118.
2. Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol. 1989;14:1477-1486.
3. Gupta NC, Esterbrooks DJ, Hilleman DE, Mohiuddin SM. Comparison of adenosine and exercise thallium-201 single-photon emission computed tomography (SPECT) myocardial perfusion imaging. The GE SPECT Multicenter Adenosine Study Group. J Am Coll Cardiol. 1992;19:248-257.
4. Taillefer R, Ahlberg AW, Masood Y, et al. Acute β-blockade reduces the extent and severity of myocardial perfusion defects with dipyridamole Tc-99m sestamibi SPECT imaging. J Am Coll Cardiol. 2003;42:1475-1483.
5. Sharir T, Rabinowitz B, Livschitz S, et al. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol. 1998;31:1540-1546.
6. Bottcher M, Refsgaard J, Madsen MM, et al. Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia. J Nucl Cardiol. 2003;10:345-352.
7. Lakkireddy D, Aronow WS, Bateman T, McGhee I, Nair C, Khan IA. Does β blocker therapy affect the diagnostic accuracy of adenosine singlephoton-emission computed tomographic myocardial perfusion imaging? Am J Ther. 2008;15:19-23.
8. Ozdemir M, Yazici GE, Turkoglu S, Timurkaynak T, Cengel A. Metoprolol does not effect myocardial fractional flow reserve in patients with intermediate coronary stenoses. Int Heart J. 2007;48:477-483.
9. Campeau L. Letter: grading of angina pectoris. Circulation. 1976;54:522-523.
10. Cerqueira MD, Weissman NJ, Dilsizian V, et al.; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-542.
11. Geleijnse ML, Elhendy A, Fioretti PM, Roelandt JR. Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol. 2000;36:2017-2027.
12. Sundereswaran L, He ZX, Verani MS, Mahmarian JJ. Influence of antianginal medications on the detection of coronary artery disease as assessed by singlephoton emission computed tomography combined with adenosine stress [abstract]. Circulation. 1996;94(suppl I):303-304.
13. Billinger M, Fleisch M, Eberli FR, Meier B, Seiler C. Collateral and collateral-adjacent hyperemic vascular resistance changes and the ipsilateral coronary flow reserve: documentation of a mechanism causing coronary steal in patients with coronary artery disease. Cardiovasc Res. 2001;49:600-608.
14. Koepfli P, Wyss CA, Namdar M, et al. β-adrenergic blockade and myocardial perfusion in coronary artery disease: differential effects in stenotic versus remote myocardial segments. J Nucl Med. 2004;45:1626-1631.
15. Billinger M, Seiler C, Fleisch M, Eberli FR, Meier B, Hess OM. Do β-adrenergic blocking agents increase coronary flow reserve? J Am Coll Cardiol. 2001;38:1866-1871.
16. 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. J Nucl Med. 1997;38:442-446.
17. Di Carli MF, Tobes MC, Mangner T, et al. Effects of cardiac sympathetic innervation on coronary blood flow. N Engl J Med. 1997;336:1208-1215.
18. Madjlessi-Simon T, Mary-Krause M, Fillette F, Lechat P, Jaillon P. Persistent transient myocardial ischemia despite β-adrenergic blockade predicts a higher risk of adverse cardiac events in patients with coronary artery disease. J Am Coll Cardiol. 1996;27:1586-1591.
19. Walker PR, Marshall AJ, Farr S, Bauminger B, Walters G, Barritt DW. Abrupt withdrawal of atenolol in patients with severe angina: comparison with the effects of treatment. Br Heart J. 1985;53:276-282.
20. Eisele G, Gilmore LL, Blanchard EB. Close clinical observation minimizes the complications of β-blocker withdrawal. Ann Pharmacother. 1994;28:849-851.
21. Croft CH, Rude RE, Gustafson N, et al. Abrupt withdrawal of β-blockade therapy in patients with myocardial infarction: effects on infarct size, left ventricular function, and hospital course. Circulation. 1986;73:1281-1290.
22. Psaty BM, Koepsell TD, Wagner EH, LoGerfo JP, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping the use of β-blockers. JAMA. 1990;263:1653-1657.